UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000034222
Receipt number R000038966
Scientific Title A phase Ib study of Nivolumab plus Trastuzumab with S-1/Capecitabine plus Oxaliplatin for HER2 positive advanced gastric cancer
Date of disclosure of the study information 2018/09/20
Last modified on 2024/03/26 11:37:35

No. Disposal Last modified on Item of update
1 Insert 2018/09/20 18:44:21
2 Update 2018/09/21 18:06:09 Anticipated trial start date
3 Update 2019/02/20 11:05:45 Recruitment status
4 Update 2019/03/26 16:59:23 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address
Address

Last name of contact person

Last name of contact person
Zip code
Address
Address
Email1
Organization
Organization
Address
Address
Tel
Email
5 Update 2019/04/01 16:33:38 Email1
6 Update 2019/10/02 11:45:56 Address
Address
TEL
7 Update 2019/11/07 18:29:47 Division name
Division name
Division name
Division name
Tel1
8 Update 2019/11/20 11:06:48 Organization
Organization
Email
9 Update 2021/03/23 12:43:18 Recruitment status
Date of IRB
Last follow-up date
10 Update 2024/03/26 11:26:45 Last follow-up date
11 Update 2024/03/26 11:37:35 Organization
Organization
Division name
Division name
Address
Email